Prion protein peptides: Optimal toxicity and peptide blockade of toxicity

Molecular and Cellular Neurosciences

Volumn 15, Issue 1, 2000, Pages 66-78

  Brown, David R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; GLIA CELL; MODEL; MOUSE; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN INTERACTION; SEQUENCE ANALYSIS;

ANIMALIA;

EID: 0033980694     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.1999.0796     Document Type: Article

References (33)

1. Betmouni S., Perry V. H. The acute inflammatory response in CNS following injection of prion brain homogenate or normal brain homogenate. Neuropathol. Appl. Neurobiol. 25:1999;20-28.
2. Brandner S., Isenmann S., Raeber A., Fischer M., Sailer A., Kobayashi Y., Marino S., Weissmann C., Aguzzi A. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature. 379:1996;339-343.
3. Brown D. R. Dependence of neurones on astrocytes in a co-culture system renders neurones sensitive to TGF-β1 induced glutamate toxicity. J. Neurochem. 72:1999;943-953.
4. Brown D. R., Herms J., Kretzschmar H. A. Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment. NeuroReport. 5:1994;2057-2060.
5. Brown D. R., Schmidt B., Kretzschmar H. A. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature. 380:1996a;345-347.
6. Brown D. R., Schmidt B., Kretzschmar H. A. A neurotoxic prion protein fragment enhances proliferation of microglia but not astrocytes in culture. Glia. 18:1996b;59-67.
7. Brown D. R., Schultz-Schaeffer W. J., Schmidt B., Kretzschmar H. A. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp. Neurol. 146:1997a;104-112.
8. Brown D. R., Herms J. W., Schmidt B., Kretzschmar H. A. Different requirements for the neurotoxicity of fragments of PrP and β-amyloid. Eur. J. Neurosci. 9:1997b;1162-1169.
9. Brown D. R., Schmidt B., Kretzschmar H. A. Expression of prion protein in PC12 is enhanced by exposure to oxidative stress. Int. J. Dev. Neurosci. 15:1997c;961-972.
10. Brown D. R., Pitschke M., Riesner D., Kretzschmar H. A. Cellular effects of a neurotoxic prion protein peptide are related to its β-sheet content. Neurosci. Res. Commun. 23:1998a;119-128.
11. Brown D. R., Schmidt B., Groschup M. H., Kretzschmar H. A. Prion protein expression in muscle cells and toxicity of a prion protein fragment. Eur. J. Cell Biol. 75:1998b;29-37.
12. Brown D. R., Schmidt B., Kretzschmar H. A. A prion protein fragment primes type 1 astrocytes to proliferation signals from microglia. Neurobiol. Dis. 4:1998c;410-422.
13. Brown D. R., Mohn C. M. Astrocytic glutamate uptake and prion protein expression. Glia. 25:1999;282-292.
14. Büeler H., Fischer M., Lang Y., Bluethmann H., Lipp H.-P., DeArmond S. J., Prusiner S. B., Aguet M., Weissmann C. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature. 356:1992;577-582.
15. Chabry J., Caughey B., Chesebro B. Specific inhibition of in vitro formation of protease resistant prion protein by synthetic peptides. J. Biol. Chem. 273:1998;13203-13207.
16. Forloni G., Angeretti N., Chiesa R., Monzani E., Salmona M., Bugiani O., Tagliavini F. Neurotoxicity of a prion protein fragment. Nature. 362:1993;543-546.
17. Giese A., Brown D. R., Groschup M. H., Feldmann C., Haist I., Kretzschmar H. A. Role of microglia in neuronal cell death in prion disease. Brain Pathol. 8:1998;449-457.
18. Hope J., Shearman M. S., Baxter H. C., Chong A., Kelly S. M., Price N. C. Cytotoxicity of prion protein (PrP106-126) differs in mechanism from the cytotoxicity activity of the Alzheimer's disease amyloid peptide Aβ25-35. Neurodegeneration. 5:1996;1-11.
19. Hope J., Reekie L. J., Hunter N., Multhaup G., Beyreuther K., White H., Scott A. C., Stack M. J., Dawson M., Wells G. A. Fibrils from brains of cows with new cattle disease contain scrapie-associated protein. Nature. 336:1988;390-392.
20. Hölscher C., Delius H., Bürkle A. Overexpression of non-convertible PrPc?114-121 in scrapie-infected mouse neuroblastoma cells leads to trans-dominant inhibition of wild-type PrPSc accumulation. J. Virol. 72:1998;1153-1159.
21. Hsiao K., Prusiner S. B. Inherited human prion diseases. Neurology. 40:1990;1820-1827.
22. Kaneko K., Peretz D., Pan K.-M., Blochberger T. C., Wille H., Gabizon R., Griffith O. H., Cohen F. E., Baldwin M. A., Prusiner S. B. Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform. Proc. Natl. Acad. Sci. USA. 92:1995;11160-11164.
23. Kaneko K., Vey M., Scott M., Pilkuhn S., Cohen F. E. COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform. Proc. Natl. Acad. Sci. USA. 94:1997a;2333-2338.
24. Kaneko K., Zulianello L., Scott M., Cooper C. M., Wallace A. C., James T. L., Cohen F. E., Prusiner S. B. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc. Natl. Acad. Sci. USA. 94:1997b;10067-10074.
25. Kascsak R. J., Rubenstein R., Merz P. A., Tonna-DeMasi M., Fresko R., Carp R. I., Wisniewski H. M., Diringer H. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril protein. J. Virol. 61:1987;3688-3693.
26. Martins V. R., Graner E., Garcia-Abreu J., DeSouza S. J., Neto V. M., Brentani R. R. Complementary hydropathy identifies a cellular prion protein receptor. Nat. Med. 3:1997;1376-1381.
27. Sc)-induced toxicity in rat cortical cell cultures. Eur. J. Pharmacol. 246:1993;261-267.
28. Prusiner S. B. Novel proteinaceous infectious particles cause scrapie. Science. 216:1982;136-144.
29. Prusiner S. B. Molecular biology of prion disease. Science. 252:1991;1515-1522.
30. Prusiner S. B., Hsiao K. Human prion disease. Ann. Neurol. 35:1994;385-395.
31. Schätzl H. M., Da Costa M., Taylor M., Cohen F. E., Prusiner S. B. Prion protein gene variation among primates. J. Mol. Biol. 245:1995;362-374.
32. Supattapone S., Bosque P., Muramoto T., Wille H., Aagaard C., Peretz D., Nguyen H.-O. B., Heinrich C., Torchia M., Safar J., Cohen F. E., DeArmond S. J., Prusiner S. B., Scott M. Prion protein of 106 residues creates an artificial transmission barrier for prion replication in transgenic mice. Cell. 96:1999;869-878.
33. Tateishi J., Kitamoto T., Doh-Ura K., Sakaki Y., Steinmetz G., Tranchant C., Warter J. M., Heldt N. Immunochemical, molecular genetic and transmission studies on a case of Gerstmann-Sträussler-Scheinker syndrome. Neurology. 40:1990;1578-1581.